Growth stocks at value prices

“America has progressed from infancy to senility without passing through a period of maturity.” So said a character in one of Ian Fleming’s short stories in 1960. He was wrong then – or, was he, as so

Andrew Van Sickle: After more than a decade of poor performance, emerging markets (EMs) have staged a comeback this year. The benchmark MSCI EM index has gained more than 20% in US dollar terms. What

China’s stockmarket is booming, but renewed animal spirits are not yet helping the wider economy, says Lee Ying Shan for CNBC. More than $3trn in market capitalisation has been added across mainland a

Age brings wisdom – or at least experience. MoneyWeek is approaching its 25th birthday (the first edition appeared on 3 November 2000), and is therefore in a better position than many publications to

They say health is wealth, but healthcare investors might disagree. The sector has had a tough time over the past few years. Policy noise in the US has been a major headwind recently, but even before

“Dr Pangloss, welcome to Wall Street,” says Randall Forsyth in Barron’s. Voltaire’s “oblivious optimist” would feel right at home as stocks in the US and Asia hit record highs, even as Russia sends dr